Labiotech.eu

News and Trends 16 Oct 2017

German Drug to Stop the Progression of Alzheimer’s Enters Phase IIb

Probiodrug is ready to start a Phase IIb trial with an Alzheimer’s drug that prevents the formation of Aβ plaques before the disease progresses. The German biotech Probiodrug is getting ready to start two Phase II trials to study the safety and efficacy of its candidate PQ912, a drug designed to intervene in the early stages of […]

October 16, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Oct 2017

Interview: On the Future of iPS Cells and why Partnering is so Important in this Field

In our first part of the interview with Dr David Hallett, Executive Vice President at Evotec, we discussed the uniqueness of Induced Pluripotent Stem Cells (iPS Cells), novel developments occurring in iPS Cell research, and the challenges researchers face. Let us have a short recap of what we have learned so far: iPS Cells were […]

October 16, 2017 - 9 minutesmins - By External Contributor

News and Trends 16 Oct 2017

New Stem Cells Could Take Cell Research and Therapies to the Next Level

British researchers have created a new type of stem cell in mice. It has even greater potential than current cell lines in research and in the clinic. Stem cells have huge potential in research and therapeutics and overcome the limitations of current cell lines – embryonic and induced pluripotent stem cells. Findings published in Nature report that researchers at […]

October 16, 2017 - 3 minutesmins - By Alex Dale

Interview 16 Oct 2017

Meet the Former Banker at the Helm of Denmark’s Healthcare Giant, Novo Holdings

Kasim Kutay has ridden the biotech investment wave. First, he helped build Morgan Stanley’s European healthcare group, then did the same at Moelis & Co and now he heads Novo Holdings, the majority shareholder of Danish household biotech names NovoZymes and Novo Nordisk. I asked him about the company’s healthcare investment strategy and his CEO […]

October 16, 2017 - 7 minutesmins - By Evelyn Warner

More News! 14 Oct 2017

Art and Biology Meet at Nonhuman Networks Exhibition in Berlin

The exhibition Nonhuman Networks at Art Laboratory Berlin invites us to connect with other organisms and rethink our relationship with the environment. For those of us living in the Western world, our whole culture seems to revolve almost exclusively around ourselves. Despite having evolved within an ecosystem with a huge and fascinating diversity, we tend […]

October 14, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

More News! 13 Oct 2017

German Biotech Gets €47M To Treat Painful Inflammatory Disease

InflaRx has raised $55M (€47M) in a Series D fundraising in order to get its lead anti-inflammatory drug, IFX-1, through late-stage development. A year after its €31M Series C, InflaRx is closing a Series D round. The company has raised a total of $55M (€47M) from a team of US investors co-led by Bain Capital Life Sciences, […]

October 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

ResearchGate publishers copyright infringement

News and Trends 13 Oct 2017

Why Might Biotechs Lose Easy Access to Scientific Papers?

Five publishers have ordered ResearchGate to take down articles. Researchers might continue to get around the paywall with Sci-Hub and other initiatives. ResearchGate, described as ‘Facebook for scientists’, has over 13 million members. It has raised more than $80M (€68M) from investors including Bill Gates and the Wellcome Trust. But, five scientific publishers including Elsevier and Wiley have clubbed […]

October 13, 2017 - 3 minutesmins - By Alex Dale

News and Trends 13 Oct 2017

Sanofi Invests €170M in French Facilities to Expand Flu Vaccine Supply

Sanofi Pasteur will expand its main vaccine manufacturing site to increase distribution of its quadrivalent flu vaccine VaxigripTetra around the world. Sanofi will invest €170M in expanding its vaccine production facilities in Val de Reuil, France, which also hosts its global vaccine distribution center, from which it currently ships 900 million vaccine doses a year. The company plans to complete the expansion by […]

October 13, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Startup Scout 13 Oct 2017

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

This week we’re in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson’s, depression and schizophrenia. Mission: Neurolixis is tackling CNS and mood diseases, a number of which lack effective treatment options at the moment. The biotech currently has two candidate drugs undergoing […]

October 13, 2017 - 2 minutesmins - By Alex Dale

News and Trends 12 Oct 2017

Can Catalonia Keep its Record Biomedical Investment After the Bank Drain?

A new study reveals Catalonia achieved a record investment in biomedicine last year. But can the region keep it up after its main banks moved out last week? CataloniaBio has released an annual report on the performance of the biomedical sector in Catalonia. The results reveal that the sector raised a record €153M in 2016, an […]

October 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Oct 2017

This New Approach Simplifies Protein Analysis

Analyzing your protein sample can be a right hassle. It takes time, energy and a LOT of nerves. Especially, when the experiment has not worked out the way one wanted it to. But there is a way around it, and this company has found the solution! The use of protein biomarkers has become an essential […]

October 12, 2017 - 5 minutesmins - By External Contributor

News and Trends 12 Oct 2017

No More Seasonal Flu Shots: British Biotech’s Universal Antiviral Raises £13M

VirionHealth kicks off the development of a broad spectrum antiviral for all influenza strains and other viruses like RSV with a £13M investment in Series A. VirionHealth is developing a new type of antiviral therapy with the potential to target multiple types of viruses at once. The treatment is based on natural antivirals called defective interfering viruses. They consist […]

October 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

German Drug to Stop the Progression of Alzheimer’s Enters Phase IIb

Interview: On the Future of iPS Cells and why Partnering is so Important in this Field

New Stem Cells Could Take Cell Research and Therapies to the Next Level

Meet the Former Banker at the Helm of Denmark’s Healthcare Giant, Novo Holdings

Art and Biology Meet at Nonhuman Networks Exhibition in Berlin

German Biotech Gets €47M To Treat Painful Inflammatory Disease

Why Might Biotechs Lose Easy Access to Scientific Papers?

Sanofi Invests €170M in French Facilities to Expand Flu Vaccine Supply

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

Can Catalonia Keep its Record Biomedical Investment After the Bank Drain?

This New Approach Simplifies Protein Analysis

No More Seasonal Flu Shots: British Biotech’s Universal Antiviral Raises £13M

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!